Integrin-targeting vectors having transfection activity
US6458026B1 · kind B1 · utility
11Cited by
0References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 29, 1999 |
| Grant date | Oct 1, 2002 |
| Priority date | — |
| Expiry date | Nov 29, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/907
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A complex that comprises (i) a nucleic acid, (ii) an integrin-binding component, for example, an integrin-binding peptide, (iii) a polycationic nucleic acid-binding component, for example, oligolysine, and (iv) a lipid component, for example, a cationic liposome, has transfection activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.